Health, Nutrition & Medicine

Fungi nutrient sensing breakthrough may aid green tech, disease control

Fungal diseases can contribute up to 20% of staple crop losses and drug-resistant fungal infections lead to some 3.8 million human deaths, globally per year. 

Weill Cornell awarded $17.4M grant to develop shorter TB treatment regimen

The researchers aim to shift TB drug development toward creating new drugs from the start to work in the combinations needed to cure tuberculosis.

Uncovering hidden complexity in a key drug target for brain disorders

Metabotropic glutamate receptors interact in varied ways with their principal regulatory proteins, according to Weill Cornell Medicine investigators. The findings could inform treatments for epilepsy, depression and anxiety disorders.

A&S offers new science, technology and society major

An innovative major in the College of Arts & Sciences is being expanded and refined to highlight its combination of science, social science and the humanities and its relevance to careers today.

Around Cornell

Stress hormone timing creates a different kind of obesity

Obesity caused by disrupted stress-hormone rhythms is metabolically very different from obesity caused by a high-fat diet, according to new research.

Device gives first view of animal brain activity in the field

Researchers will be able to track the brainwaves of animals as they move in natural habitats and interact with each other – complex behaviors that have been impossible to study in the lab.

Antifungal therapy restores gut microbiome in IBD patients

A commonly used systemic antifungal medication may help reduce symptoms in a subset of patients with inflammatory bowel disease.

Model helps scientists build better protein-degrading therapies

A team of Weill Cornell Medicine investigators has developed a computer model that will help scientists more efficiently develop protein-destroying therapies, a newer type of treatment that is particularly promising for cancer. 

Folic acid does not elevate formaldehyde in mice and humans

Folic acid does not elevate toxic formaldehyde in the body, according to a new study on mice and human cancer patients who consumed high doses.